Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

European Journal of Pharmacology

Journal
uri icon
  • Overview
  • Identity
  • View All
scroll to property group menus

Overview

articles

  • Carnosic acid attenuates cartilage degeneration through induction of heme oxygenase-1 in human articular chondrocytes.  830:1-8. 2018
  • The dark side of emotion: The addiction perspective.  753:73-87. 2015
  • The triple reuptake inhibitor dov 216,303 induces long-lasting enhancement of brain reward activity as measured by intracranial self-stimulation in rats.  693:51-56. 2012
  • Both gaba(b) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats.  655:52-58. 2011
  • Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice.  649:210-217. 2010
  • Kr-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.  632:93-102. 2010
  • In vitro pharmacological selectivity profile of oseltamivir prodrug (tamiflu (r)) and active metabolite.  628:6-10. 2010
  • Loganin improves learning and memory impairments induced by scopolamine in mice.  619:44-49. 2009
  • Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist.  592:158-159. 2008
  • Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist.  590:423-429. 2008
  • Time-dependent involvement of cAMP and cGMP in consolidation of object memory: Studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.  558:107-112. 2007
  • Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.  557:44-48. 2007
  • Activators of potassium m currents have anticonvulsant actions in two rat models of encephalitis.  555:23-29. 2007
  • Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats.  501:235-237. 2004
  • Reinforcing effect of pseudoephedrine isomers and the mechanism of action.  493:117-125. 2004
  • No evidence for G-protein-coupled epsilon receptor in the brain of triple opioid receptor knockout mouse.  492:131-136. 2004
  • 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.  487:125-132. 2004
  • Ethanol-induced increases in neuroactive steroids in the rat brain and plasma are absent in adrenalectomized and gonadectomized rats.  484:241-247. 2004
  • Systemic galnon, a low-molecular weight galanin receptor agonist, reduces heat hyperalgesia in rats with nerve injury.  482:133-137. 2003
  • Agonist properties of putative small-molecule somatostatin sst(2) receptor-selective antagonists.  465:211-218. 2003
  • Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice.  446:103-109. 2002
  • Pharmacological characterisation of the goldfish somatostatin sst(5) receptor.  436:173-186. 2002
  • Lack of evidence for cross-competition between vasoactive intestinal peptide and somatostatin at their respective receptors.  426:165-173. 2001
  • Effect of nociceptin/orphanin FQ on the rewarding properties of morphine.  404:153-159. 2000
  • beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells.  402:R1-R3. 2000
  • The galanin receptor antagonist m40 blocks the central cardiovascular actions of the galanin n-terminal fragment (1-15).  399:197-203. 2000
  • Neurobiological mechanisms by which nicotine mediates different types of anxiety.  393:231-236. 2000
  • Antagonism of heroin and morphine self-administration in rats by the morphine-6 beta-glucuronide antagonist 3-o-methylnaltrexone.  383:115-119. 1999
  • Chronic ethanol enhances muscarinic receptor-mediated activator protein-1 (ap-1) DNA binding in cerebellar granule cells.  383:203-208. 1999
  • Gamma-hydroxybutyrate inhibits excitatory postsynaptic potentials in rat hippocampal slices.  380:109-116. 1999
  • Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat.  375:115-120. 1999
  • A heroin-, but not a cocaine-expecting, self-administration state preferentially alters endogenous brain peptides.  365:175-182. 1999
  • Region specific expression of nmda receptor nr1 subunit mrna in hypothalamus and pons following chronic morphine treatment.  365:47-54. 1999
  • Genomic cloning and species-specific properties of the recombinant canine beta(3)-adrenoceptor.  363:217-227. 1998
  • I-125 Tyr(3) octreotide labels human somatostatin sst(2) and sst(5) receptors.  348:311-320. 1998
  • Opposite effects of stress on dopamine release in the limbic system of drug-naive and chronically amphetamine-treated rats.  337:219-222. 1997
  • Intravenous self-administration of heroin, cocaine, and the combination in balb/c mice.  326:119-125. 1997
  • The anxiolytic-like effects of the neurosteroid allopregnanolone: Interactions with gaba(a) receptors.  325:1-7. 1997
  • Dextromethorphan reduces intravenous cocaine self-administration in the rat.  321:279-283. 1997
  • Fragments of galanin message-associated peptide (GMAP) modulate the spinal flexor reflex in rat.  318:301-306. 1996
  • Adenosine a(2a) receptors modulate the binding characteristics of dopamine d-2 receptors in stably cotransfected fibroblast cells.  316:325-331. 1996
  • Inhibition of dynorphin-converting enzymes prolongs the antinociceptive effect of intrathecally administered dynorphin in the mouse formalin test.  314:61-67. 1996
  • N-methyl-d-aspartate-induced enhancement of activator protein-1 DNA binding activity is blocked by ethanol in cerebellar granule cells.  309:307-310. 1996
  • A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity.  309:195-200. 1996
  • Dopamine partial receptor agonists reduce ethanol intake in the rat.  296:233-238. 1996
  • Peptoid cck receptor antagonists: Pharmacological evaluation of ccka, cckb and mixed ccka/b receptor antagonists.  286:185-191. 1995
  • Gaba(a) receptor antagonism in the extended amygdala decreases ethanol self-administration in rats.  283:151-159. 1995
  • The dopamine-receptor agonist 7-oh-dpat modulates the acquisition and expression of morphine-induced place preference.  274:47-55. 1995
  • Antagonistic regulation of alpha(2)-adrenoceptors by neuropeptide-y receptor subtypes in the nucleus-tractus-solitarii.  271:201-212. 1994
  • Evidence for an antagonistic angiotensin-ii alpha(2)-adrenoceptor interaction in the nucleus-tractus-solitarii.  262:271-282. 1994
  • Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat.  262:1-10. 1994
  • Biological activities of two endogenously occurring N-terminally extended forms of galanin in the rat spinal cord.  259:151-156. 1994
  • Galanin message-associated polypeptide (GMAP) does not affect insulin secretion from isolated islets.  259:79-82. 1994
  • Intracisternally injected galanin-(1-15) modulates the cardiovascular-responses of galanin-(1-29) and the 5-ht1a receptor agonist 8-oh-dpat.  257:257-265. 1994
  • Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat.  253:45-51. 1994
  • Characterization of galanin and 5-ht1a receptor coupling to adenylyl-cyclase in discrete regions of the rat-brain.  269:209-217. 1994
  • Influence of Ca2+ channel agonists and antagonists on the post-rest staircase.  237:83-92. 1993
  • The c-terminal neurotensin-(8-13) fragment potently modulates rat neostriatal dopamine-d(2) receptors.  234:125-128. 1993
  • Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35.  232:35-39. 1993
  • Evidence for specific n-terminal galanin fragment binding-sites in the rat-brain.  224:203-205. 1992
  • In vitro study of a novel atypical beta-adrenoceptor agonist, SM-11044.  216:207-215. 1992
  • The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion.  210:183-188. 1992
  • Centrally coinjected galanin and a 5-ht1a agonist act synergistically to produce vasodepressor responses in the rat.  204:87-95. 1991
  • Galanin-induced inhibition of insulin secretion from rat islets: effects of rat and pig galanin and galanin fragments and analogues.  203:111-114. 1991
  • Inhibition of prolactin secretion by endothelin-3 is pertussis toxin-sensitive.  198:223-225. 1991
  • The N-terminal 1-16, but not C-terminal 17-29, galanin fragment affects the flexor reflex in rats.  182:137-141. 1990
  • Two pharmacological classes of quisqualate-induced electrical responses in rat retinal ganglion cells in vitro.  174:9-22. 1989
  • Pharmacologic profile of lipoxin-a5 and lipoxin-b5 - new biologically-active eicosanoids.  163:55-60. 1989
  • Galanin inhibits the muscarinic stimulation of phosphoinositide turnover in rat ventral hippocampus.  148:479-480. 1988
  • Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (gaba), dynorphin-a and substance-p.  147:411-420. 1988
  • Altered binding-properties of beta-adrenergic receptors and lack of coupling to adenylate-cyclase in p815 mastocytoma-cells.  108:133-141. 1985
  • In vitro and in vivo inhibition of [3H]imipramine binding by cadmium.  90:289-292. 1983
  • Adrenal steroid-induced changes in beta-adrenergic-receptor binding in rat hippocampus.  74:37-41. 1981
  • Lithium treatment decreases blood-pressure in genetically hypertensive rats.  76:411-415. 1981
  • Studies on the protective effect of prostacyclin in acute myocardial ischemia.  56:95-103. 1979
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0014-2999

Electronic International Standard Serial Number (EISSN)

  • 1879-0712

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support